Andlauer Healthcare Group Inc.
AND.TO · TSX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | CA$0 | CA$0 | CA$0 | CA$0 |
| % Growth | -5.7% | -1.3% | 5.4% | – |
| Cost of Goods Sold | CA$0 | CA$0 | CA$0 | CA$0 |
| Gross Profit | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 22.9% | 22.1% | 23.5% | 23.3% |
| R&D Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| G&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| SG&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Sales & Mktg Exp. | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Income | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 12.1% | 13% | 15.9% | 14.9% |
| Other Income/Exp. Net | -CA$0 | CA$0 | -CA$0 | -CA$0 |
| Pre-Tax Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Tax Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Net Income | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 8.6% | 12.2% | 10.4% | 10.2% |
| EPS | 0.34 | 0.5 | 0.45 | 0.41 |
| % Growth | -32% | 11.1% | 9.8% | – |
| EPS Diluted | 0.34 | 0.5 | 0.44 | 0.41 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Interest Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Depreciation & Amortization | CA$0 | CA$0 | CA$0 | CA$0 |
| EBITDA | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 24.5% | 27.3% | 26% | 26.2% |